Hinge Health (HNGE) has been added to a wide range of Russell indexes, including the Russell 3000 and Russell 2000 families. This change may affect how many institutional investors gain exposure to the stock.

Recent trading shows strong momentum for Hinge Health, with a 30 day share price return of 32.11% and a 90 day share price return of 114.47%. The 1 year total shareholder return is 80.25%, suggesting sentiment has strengthened despite a 1 day share price decline of 1.20% to $84.05.

If you are looking for more ideas in this corner of the market, it is a good time to scan other healthcare focused AI opportunities through the 40 healthcare AI stocks.

With Hinge Health trading near its recent highs and sitting only slightly above the average analyst price target, the key question now is whether the stock still offers upside or if the market is already pricing in future growth.

Most Popular Narrative: 29.3% Overvalued

Hinge Health last closed at $84.05, while the most followed narrative anchors on a fair value of $65.00. This points to a material value gap based on long term assumptions.

The assumed bearish price target for Hinge Health is $65.0, which represents up to two standard deviations below the consensus price target of $82.07. This valuation is based on what can be assumed as the expectations of Hinge Health's future earnings growth, profit margins and other risk factors from analysts on the more bearish end of the spectrum.

Want to see what justifies that lower fair value for Hinge Health? The narrative leans on assertive revenue growth, a sharp profit swing and a premium earnings multiple. Curious how those pieces fit together into $65.00?

Result: Fair Value of $65.00 (OVERVALUED)

However, Hinge Health could still surprise in either direction if AI driven efficiency gains hold up or if newer services like HingeSelect and Migraine Care gain more traction.

Another View: SWS DCF Model Points To Undervaluation

The bearish narrative around Hinge Health leans on a $65.00 fair value, but the SWS DCF model presents a different perspective. On that view, Hinge Health trades about 72% below an estimated future cash flow value of $304.22, raising the question of which story investors should focus on.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Hinge Health for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 44 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If sentiment around Hinge Health feels mixed after reviewing the narratives, quickly examine the numbers yourself and form your own view with the 3 key rewards.

Looking for more investment ideas beyond Hinge Health?

If you want to keep sharpening your edge after reviewing Hinge Health, use the Simply Wall St screener to surface fresh, data driven opportunities tailored to your style.

• Target potential bargains by zeroing in on companies that combine quality with attractive pricing through the 44 high quality undervalued stocks.
• Prioritise resilience by focusing on businesses that pair prudent debt levels with solid fundamentals using the solid balance sheet and fundamentals stocks screener (47 results).
• Spot under the radar opportunities before they hit everyone’s radar by filtering with the screener containing 18 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.